Pharma-Bio Serv Inc.

05/15/2026 | Press release | Distributed by Public on 05/15/2026 15:06

Proxy Results (Form 8-K)

Item 5.07. Submission of Matters to a Vote of Security Holders.

On May 15, 2026, Pharma-Bio Serv, Inc. (the "Company") held its 2026 Annual Meeting of Stockholders (the "Annual Meeting"). Below is a summary of the proposals and corresponding votes.

Irving Wiesen was elected as a Class I director to serve for a term until the 2029 Annual Meeting of Stockholders or until his successor is duly elected and qualified. Irving Wiesen received the following votes:

Nominee

Votes For

Votes Withheld

Irving Wiesen

10,208,071

195,625

There were 2,839,645 broker non-votes on this proposal.

The ratification of the selection of Crowe PR PSC as the Company's independent certified public accountants for the fiscal year ending October 31, 2026 received the following votes:

Votes For

Votes Against

Abstain

13,241,794

3

1,544

There were no broker non-votes on this proposal.

Pharma-Bio Serv Inc. published this content on May 15, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on May 15, 2026 at 21:06 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]